4D-Nucleofector ® – Stretching Transfection Dimensions Dr. Nazim El-Andaloussi Lonza Cologne,...
-
Upload
evan-lambert -
Category
Documents
-
view
224 -
download
1
Transcript of 4D-Nucleofector ® – Stretching Transfection Dimensions Dr. Nazim El-Andaloussi Lonza Cologne,...
4D-Nucleofector® – Stretching Transfection Dimensions
Dr. Nazim El-Andaloussi
Lonza Cologne, Germany
slide 2
Introduction The Principle of the Amaxa® Nucleofector® Technology Available platforms
Details about the 4D-Nucleofector® The Core Unit The X-Unit The Operation Software Consumables Protocol Transfer
Nucleofection and Stem Cells
Summary: System key benefits
Agenda
slide 3
NotebookControl Unit
Nucleofection® – The Principle
Other transfection methods
High transfection efficiency combined with low mortality DNA is directed into the nucleus giving faster gene expression
Nucleofection®
slide 4
Primary NHDF-neo cells were transfected with TMR-labeled
plasmid DNA encoding GFP, fixed after 2h in 3.5% PFA and
analyzed by confocal microscopy.
(R)R-DNA GFP DAPI Merge
DNA is Delivered Into Cytoplasm and Nucleus
2 hrs
slide 5
Simple Handling – Optimized Protocolsstep 1
Harvest cells of interest
step 3
Nucleofector® Solution with Supplement
Mix
cells DNA or siRNA
transfer to an amaxa certified cuvette
Select Nucleofector® program
Insert cuvette
Press start button “X”
Rinse cuvette with culture medium and transfer to culture dish
expression detected as early as 3-8 hours
& combine with:
step 2
step 4
slide 6
Device Nucleofector® 2b*96-well Shuttle®
4D-Nucleofector®
HT Nucleofector®
Throughput Very low (1) Medium (96) Low (1-16) High (384)
Reaction volume 100µl 20µl 100µl and 20µl 20µl
Electrode material AluminumConductive
polymerConductive
polymerConductive
Polymer
Cell numbers (orders of magnitude)
105 to 107 (2) 104 to 106 (2) 104 to 107 (3) 104 to 106 (2)
Adherent Nucleofection
No Yes Yes Yes
Shuttle compatibility No - Yes No
Our Product Family – A Technical Comparison
* Nucleofector without Shuttle connectivity
slide 7
NotebookControl Unit
The Amaxa® Nucleofector® Technology
Efficient transfection of primary cells & cell lines Applications in Neurology, Metabolic diseases,
Cancer, Immunology, Cardiology and other Therapeutic areas
Versatility in substrate delivery DNA, siRNA, miRNA, mRNA, morpholinos Peptides, proteins, antibodies Small molecules
Applicable for Assay development RNAi and cDNA screening
Target validation
slide 8
Introduction The Principle of the Amaxa® Nucleofector® Technology Available platforms
Details about the 4D-Nucleofector® The Core Unit The X-Unit The Operation Software Consumables Protocol Transfer
Nucleofection and Stem Cells
Summary: System key benefits
Agenda
slide 9
Overview 4D-Nucleofector® System
A new, modular system offering advanced performance and convenience. Comprising one Core Unit and several Functional Modules the system is designed for maximum flexibility.
Features
1D Easy Transfection of various cell numbers with same conditions
2D Fast Different throughput, from one to 16 wells in 10 seconds
3D Flexible Nucleofection of cells in adherence for assays at various stages
4D Future-proof Modular system for upcoming transfection challenges
slide 10
Straight, very elegant, valuable and distinguishable Fold-away Graphical User Interface
Electrically driven drawer for cuvette/sample retainer
Could be assembled side by side or on top of each other
Noble housing, shell made of metal
Core Unit
X-Unit
4D-Nucleofector® System
Y-Unit
slide 11
NotebookControl Unit
Amaxa® Nucleofector®
II.S
Amaxa® Nucleofector® 96-well Shuttle®
Amaxa® Nucleocuvette® Plate
Intuitive Software 96 different programs /
plate 3-4 min / plate Connection via USB
Amaxa® Nucleofector® 96-well Shuttle® System
USB
4D-Nucleofector® Core and X-Unit
+
slide 12
4D-Nucleofector® System – The Core Unit
The Control Unit of the 4D-Nucleofector® System 5,7’’ foldable touch screen to operate the system (A) Operated by intuitive operation software Controls several functional units Comprises USB and serial connectivity for the 96-well Shuttle® (B) USB port for software update and data transfer (C)
A
B
C
slide 13
4D-Nucleofector® System – The X-Unit
The Unit supporting Nucleofection® of various cell numbers
Features positions for Nucleocuvette® Strips (A) and 100µl CP-cuvettes (B) Comprises HV connectivity for the Shuttle (C) Seamless transfer of conditions between Nucleofection® Vessels Suited for transfection of cells in adherence (ACT-Strips)
A
B
C
slide 14
4D-Nucleofector® System – Operation Software
The intuitive tool operating the 4D-Nucleofector® System Easy-to-use through up-to-date touch screen interface Comes with predefined Nucleofection® Parameters and Experiments Supports data transfer / software update via USB storage device PC-Editor software included to predefine experiments off-line
slide 15
4D-Nucleofector® System — Consumables
Consumables tailored to customer needs Kits supporting Nucleofection in 16-well Nucleocuvette Strips (20µl) (A) Kits supporting Nucleofection in single CP-cuvettes (100µl) (B) Three kits for cell lines; five kits for primary cells Cell line and primary cell optimization kits Kits for adherent cell Nucleofection
BA
slide 16
Reduction of Specific Kits
4D-Nucleofector® Kit Concept: 5 Primary Cell Kits (P1-5) 1 Primary Cell Optimization Kit 3 Cell Line Kits (SE, SF, SG) 1 Cell Line Optimization Kit
4D-Nucleofector OPs: Modified 96-well Shuttle OPs with ordering information for 20µl
and 100µl Kits.
slide 17
Cell Optimization Strategy
FINE TUNE
Cell Line Optimization
Easy Optimization Test three solutions for cell lines or five solutions for primary cells each with
15 different programs Based on best solution and program combination, fine tune transfection
efficiency or viability
FINE TUNE
Primary Cell Optimization
P1 P2 P3 P4 P5
SE SF SG
slide 18
Cell Line Optimization Strategy
Sol. SE SF SG
Row 1 2 1 2 1 2
A CA-137 DS-150 CA-137 DS-150 CA-137 DS-150
B CM-138 DS-120 CM-138 DS-120 CM-138 DS-120
C CM-137 EH-100 CM-137 EH-100 CM-137 EH-100
D CM-150 EO-100 CM-150 EO-100 CM-150 EO-100
E DN-100 EN-138 DN-100 EN-138 DN-100 EN-138
F DS-138 EN-150 DS-138 EN-150 DS-138 EN-150
G DS-137 EW-113 DS-137 EW-113 DS-137 EW-113
H DS-130 Control DS-130 Control DS-130 Control
Strip 1 Strip 2 Strip 3
slide 19
4D-Nucleofector® System – Optimized Protocols
Excellent performance on various cell numbers 4D-Nucleofector® performs equally compared to the 96-well
Shuttle®
% T
rans
fect
ion
effic
ienc
y
4D-Nucleofector® 96-well Shuttle®
0
10
20
30
40
50
60
70
80
90
100
Jurkat HUVEC T Cells NIH-3T3 K562
slide 20
Same conditions for different volumes / cell numbers 20µl and 100µl Nucleocuvettes® working with the same
parameters – no additional optimization required
4D-Nucleofector® System – Protocol Transfer
0
20
40
60
80
100
CHO-K1 Human T cells Rat neurons Jurkat HeLa-S3 NIH-3T3 NHDF-neo
TE 20µl TE 100µl VIAB 20 µl VIAB 100 µl
TEVIA
%
slide 21
Introduction The Principle of the Amaxa® Nucleofector® Technology Available platforms
Details about the 4D-Nucleofector® The Core Unit The X-Unit The Operation Software Consumables Protocol Transfer
Nucleofection and Stem Cells
Summary: System key benefits
Agenda
slide 22
Transfection Efficiency *
Viability
Adipose Stem Cells (human) 76 %
CD34+ (human) 71% – 83% 62%
MSC (human) 47% – 78% 65 – 78%
ES Cells (human) 45% – 78% 50 – 98%
ES Cells (mouse) 77% - 90% 68 – 95%
NSC (cow) 65% 75%
NSC (human) 90%
NSC (mouse) 60% 80%
NSC (rat) 42% – 90% 75%
Nucleofection of Stem Cells
* pmaxGFP
slide 23
Nucleofection™ of human Embryonic Stem Cells
0
10
20
30
40
50
60
70
80
90
100
H1H9
H9.2
Hues-
9
BG01V
Custo
mer
Efficiency Viability
Data for Nucleofection™ of human stem cells are compiled from experiments performed by leading stem cell research customers
slide 24
Data kindly provided by Jennifer Moore, Rutgers University, Piscataway, USA
GFPSSEA4OCT4Nuclei
H9 cells express pluripotency markers SSEA4 and OCT4 24 hours post Nucleofection™ of pmaxGFP™ reporter vector
Human ES cells maintain pluripotency
0
20
40
60
80
100
SSEA4 GFP SSEA4/GFP% P
osi
tive
ce
lls (
flow
cyt
om
etr
y)
slide 25
Nucleofection™ for generation of iPS cells
High transfection efficiencies for human chondrocytes, dermal fibroblasts (NHDF) or mouse embryonic fibroblasts – potential for generation of iPS via Nucleofection™
Mouse Embryonic Fibroblast
Photograph courtesy of Dr. H. Hermanns and Prof. P.H. Heinrich, University of Aachen, Germany
Tra
nsf
ect
ion
Eff
icie
ncy
an
d v
iab
ility
(%
)
0
20
40
60
80
100
NHDF-adult* NHDF-neo* Human chondrocytes*
Transfection Efficiency Viability
slide 26
Virus-free induction of pluripotency and subsequent excision of reprogramming factors; Nature, 9 Apr 2009; 458 (7239)
Generation of mouse-induced pluripotent stem cells by transient expression of a single nonviral polycistronic vector PNAS June 2, 2009 vol. 106 no. 22 8918-8922
Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures Cell Research (2011) 21:518-529.
Efficient Feeder-Free Episomal Reprogramming with Small Molecules (2011) PLoS ONE 6(3): e17557.
Nucleofection™ for generation of iPS cells
slide 27
Introduction The Principle of the Amaxa® Nucleofector® Technology Available platforms
Details about the 4D-Nucleofector® The Core Unit The X-Unit The Operation Software Consumables Protocol Transfer
Nucleofection and Stem Cells
Summary: System key benefits
Agenda
slide 28
Major Benefits of the 4D-Nucleofector®
Easy-to-use through intuitive software and touch screen interface
Upgradeable by adding new Functional Modules
Customizable through its modular architecture
Uses existing 96-well Shuttle® Protocols
The use of CP electrodes allows fewer solutions for primary cells
Supports Nucleofection® of various cell numbers with same conditions
Allows Nucleofection® of cells in adherence
Excellent technical and application support by Nucleofection® Experts
System Key Benefits
Thank you for your kind attention!